WO2001001152A1 - Method and apparatus for presenting thrombosis and hemostasis assay data - Google Patents
Method and apparatus for presenting thrombosis and hemostasis assay data Download PDFInfo
- Publication number
- WO2001001152A1 WO2001001152A1 PCT/US2000/018310 US0018310W WO0101152A1 WO 2001001152 A1 WO2001001152 A1 WO 2001001152A1 US 0018310 W US0018310 W US 0018310W WO 0101152 A1 WO0101152 A1 WO 0101152A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- time
- profile
- sample
- dependent measurement
- data
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/4905—Determining clotting time of blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/22—Haematology
- G01N2800/224—Haemostasis or coagulation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/22—Haematology
- G01N2800/226—Thrombotic disorders, i.e. thrombo-embolism irrespective of location/organ involved, e.g. renal vein thrombosis, venous thrombosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/38—Pediatrics
- G01N2800/385—Congenital anomalies
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/60—ICT specially adapted for the handling or processing of medical references relating to pathologies
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020017016754A KR20020042539A (en) | 1999-06-30 | 2000-06-30 | Method and apparatus for presenting thrombosis and hemostasis assay data |
CA002377528A CA2377528C (en) | 1999-06-30 | 2000-06-30 | Method and apparatus for presenting thrombosis and hemostasis assay data |
DE60028374T DE60028374T2 (en) | 1999-06-30 | 2000-06-30 | METHOD AND APPARATUS FOR PRESENTING DATA OF THROMBOSIS AND HAEMOSTASE ASSAYS |
EP00947001A EP1188060B1 (en) | 1999-06-30 | 2000-06-30 | Method and apparatus for presenting thrombosis and hemostasis assay data |
JP2001507105A JP2003529046A (en) | 1999-06-30 | 2000-06-30 | Method and apparatus for presenting test data for thrombotic congestion |
AU60676/00A AU768436B2 (en) | 1999-06-30 | 2000-06-30 | Method and apparatus for presenting thrombosis and hemostasis assay data |
AU2004201011A AU2004201011B2 (en) | 1999-06-30 | 2004-03-10 | Method and apparatus for presenting thrombosis and hemostasis assay data |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/345,080 US6502040B2 (en) | 1997-12-31 | 1999-06-30 | Method for presenting thrombosis and hemostasis assay data |
US09/345,080 | 1999-06-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001001152A1 true WO2001001152A1 (en) | 2001-01-04 |
WO2001001152A9 WO2001001152A9 (en) | 2002-05-02 |
Family
ID=23353417
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/018310 WO2001001152A1 (en) | 1999-06-30 | 2000-06-30 | Method and apparatus for presenting thrombosis and hemostasis assay data |
Country Status (10)
Country | Link |
---|---|
US (1) | US6502040B2 (en) |
EP (1) | EP1188060B1 (en) |
JP (1) | JP2003529046A (en) |
KR (1) | KR20020042539A (en) |
AT (1) | ATE328327T1 (en) |
AU (1) | AU768436B2 (en) |
CA (1) | CA2377528C (en) |
DE (1) | DE60028374T2 (en) |
ES (1) | ES2270850T3 (en) |
WO (1) | WO2001001152A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008040827A1 (en) | 2006-10-02 | 2008-04-10 | Lafuente Flo, Rosa | Improved cover for motorcycle helmets |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003083490A2 (en) * | 2001-06-29 | 2003-10-09 | Biomerieux, Inc. | Method for predicting antiphospholid syndrome |
US9125989B2 (en) | 2003-01-23 | 2015-09-08 | Debiotech S.A. | Device for determining the characteristics of peritoneal membrane |
DE60333983D1 (en) * | 2002-01-28 | 2010-10-14 | Debiotech Sa | peritoneal dialysis |
JP5602027B2 (en) * | 2008-02-14 | 2014-10-08 | オリオン ディアグノスティカ オサケ ユキチュア | How to predict the nature of the future |
US20110104725A1 (en) * | 2008-05-02 | 2011-05-05 | Advanced Liquid Logic, Inc. | Method of Effecting Coagulation in a Droplet |
US20090298103A1 (en) * | 2008-05-20 | 2009-12-03 | The University Of Vermont And State Agriculture College | Predicting hemostatic risk; dependence on plasma composition |
JP5982976B2 (en) * | 2012-04-13 | 2016-08-31 | ソニー株式会社 | Blood coagulation system analyzer, blood coagulation system analysis method and program thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5715821A (en) * | 1994-12-09 | 1998-02-10 | Biofield Corp. | Neural network method and apparatus for disease, injury and bodily condition screening or sensing |
US5834223A (en) * | 1994-11-14 | 1998-11-10 | The Scripps Research Institute | Method for diagnosis of thrombotic disorders |
US5856114A (en) * | 1994-03-21 | 1999-01-05 | The University Of Vermont | Immunologic detection of factor VA fragments in hemorrhagic and thrombotic clinical settings |
Family Cites Families (90)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3307392A (en) | 1964-05-04 | 1967-03-07 | Research Corp | Automatic prothrombin timer apparatus and method |
US3458287A (en) | 1965-04-29 | 1969-07-29 | Medical Laboratory Automation | Method and means of determining endpoint times in blood clotting tests |
US3658480A (en) | 1970-04-13 | 1972-04-25 | Bio Data Corp | Coagulation timing apparatus, and method |
US4047890A (en) | 1973-11-01 | 1977-09-13 | Bio/Data Corporation | Method and apparatus for determining deficiencies in enzymatic reactors particularly clotting factor levels in blood plasmas |
SU590665A1 (en) | 1976-02-11 | 1978-01-30 | Новосибирский государственный медицинский институт | Method of investigating |
US4040788A (en) | 1976-04-05 | 1977-08-09 | Sanford L. Simons | Apparatus, instrumentation, and method for comparing samples |
DE2635081C3 (en) | 1976-08-04 | 1980-08-07 | Bio/Data Corp., Willow Grove, Pa. (V.St.A.) | Method and apparatus for determining blood plasma coagulation factor levels |
FR2364453A1 (en) | 1976-09-08 | 1978-04-07 | Lacombe Pierre | Measurement of blood plasma coagulation time - using optical density method, suitable for oxalated or citrated plasma |
US4199748A (en) | 1976-11-01 | 1980-04-22 | Rush-Presbyterian-St. Luke's Medical Center | Automated method and apparatus for classification of cells with application to the diagnosis of anemia |
JPS5451893A (en) | 1977-09-30 | 1979-04-24 | Sankyo Co | Measuring of blood coagulating time |
JPS5822703B2 (en) | 1978-08-30 | 1983-05-10 | 三共株式会社 | Blood coagulation measurement method |
US4289498A (en) | 1979-01-08 | 1981-09-15 | Ortho Diagnostics, Inc. | One-stage prothrombin assay and compositions useful therein |
US4766083A (en) | 1982-04-04 | 1988-08-23 | Wako Pure Chemical Industries, Ltd. | Method for the photometric determination of biological agglutination |
SU1076086A1 (en) | 1982-12-28 | 1984-02-29 | Всесоюзный Научно-Исследовательский И Конструкторский Институт Медицинской Лабораторной Техники | Hemocoagulograph |
US4705756A (en) | 1983-01-26 | 1987-11-10 | University Of Medicine And Dentistry Of New Jersey | Method of determining the existence and/or the monitoring of a pathological condition in a mammal |
EP0115459A3 (en) | 1983-01-26 | 1986-11-20 | University Of Medicine And Dentistry Of New Jersey | Hematological prediction of sepsis and other disease states |
JPS59203959A (en) | 1983-05-04 | 1984-11-19 | Toa Medical Electronics Co Ltd | Measuring device for blood clotting time |
JPH0695095B2 (en) | 1983-11-25 | 1994-11-24 | 株式会社島津製作所 | Fully automatic blood analyzer |
DE3502878A1 (en) | 1985-01-29 | 1986-07-31 | Boehringer Mannheim Gmbh, 6800 Mannheim | METHOD FOR DETERMINING THE FIBRINOLYTIC STATE OF PLASMA |
JPS61272655A (en) | 1985-05-28 | 1986-12-02 | Iryo Kogaku Kenkyusho:Kk | Quantitative discrimination method for platelet agglutination power |
GB8516081D0 (en) | 1985-06-25 | 1985-07-31 | Ciba Geigy Ag | Assay & purification of amyloid components |
US4902630A (en) | 1985-07-22 | 1990-02-20 | Abbott Laboratories | Fluorescence polarization immunoassy and reagents for measurement of c-reactive protein |
US5593897A (en) | 1988-04-04 | 1997-01-14 | Northwestern University | Binding of immune complexes by modified forms of C-reactive protein |
ATE134880T1 (en) | 1988-04-04 | 1996-03-15 | Lawrence A Potempa | BINDING OF IMMUNE COMPLEXES THROUGH MODIFIED FORMS OF C-REACTIVE PROTEINS |
US4965725B1 (en) | 1988-04-08 | 1996-05-07 | Neuromedical Systems Inc | Neural network based automated cytological specimen classification system and method |
US5156974A (en) | 1988-05-27 | 1992-10-20 | Biodata Corporation | Method for determining the fibrinogen level of a blood sample |
US5003065A (en) | 1988-06-14 | 1991-03-26 | Carey Merritt | Compounds and process for measuring c-reactive protein |
US5055412A (en) | 1989-03-21 | 1991-10-08 | Proksch Gary J | Factor sensitive reagent for testing of blood coagulation containing ellagic acid and divalent metal ions and method of making the same |
US5500345A (en) | 1989-04-25 | 1996-03-19 | Iatron Laboratories, Inc. | Hybridomas producing monoclonal antibodies specific for C-reactive protein and methods for detection of C-reactive protein |
CA2057058C (en) | 1989-06-27 | 2000-09-05 | Joan N. Siegel | Monoclonal antibodies to c-reactive protein |
WO1991001383A1 (en) | 1989-07-14 | 1991-02-07 | Michigan State University | Method for diagnosing blood clotting disorders |
US5051357A (en) | 1989-07-14 | 1991-09-24 | Board Of Trustees Operating Michigan State University | Method and assay using inactivation of factors Va and VIIIa by activated Protein C to diagnose thrombic disease or assay for Protein C and kit therefor |
JP3055933B2 (en) | 1989-07-20 | 2000-06-26 | アナリティカル・コントロール・システムズ・インコーポレーテッド | Improved stable coagulation control |
SU1691741A1 (en) | 1989-08-25 | 1991-11-15 | Донецкий государственный медицинский институт | Method for prognostication of hemorrhagic complications secondary to traumatosis |
US4998535A (en) | 1989-09-05 | 1991-03-12 | Univ. of Washington New England Medical Center Hospitals, Inc. | Thrombolysis predictive instrument |
US5262303A (en) | 1989-10-13 | 1993-11-16 | Trustees Of Boston University | Ligand/anti-ligand assays for adherent proteins |
US5646046A (en) | 1989-12-01 | 1997-07-08 | Akzo Nobel N.V. | Method and instrument for automatically performing analysis relating to thrombosis and hemostasis |
IE904244A1 (en) | 1989-12-01 | 1991-06-05 | Akzo Nv | Direct fibrinogen assay |
US5169786A (en) | 1989-12-19 | 1992-12-08 | Ortho Diagnostic Systems, Inc. | Method of determining levels of extrinsic and intrinsic clotting factors and protein c |
EP0525035B1 (en) | 1990-04-17 | 1996-07-03 | Analytical Control Systems, Inc. | Coagulation assays and reagents |
US5862304A (en) | 1990-05-21 | 1999-01-19 | Board Of Regents, The University Of Texas System | Method for predicting the future occurrence of clinically occult or non-existent medical conditions |
US5218529A (en) | 1990-07-30 | 1993-06-08 | University Of Georgia Research Foundation, Inc. | Neural network system and methods for analysis of organic materials and structures using spectral data |
JPH04254760A (en) | 1991-01-30 | 1992-09-10 | Eiken Chem Co Ltd | Serum amyloid a reference substance and setting method thereof |
US5221628A (en) | 1991-03-19 | 1993-06-22 | Northwestern University | Binding of aggregated immunoglobulin or immune complexes by serum amyloid P component |
RU2012877C1 (en) | 1991-04-01 | 1994-05-15 | Белорусский научно-исследовательский институт охраны материнства и детства | Method of prognosticating pulmonary disorder syndrome in premature neonates |
EP0525273B1 (en) | 1991-08-02 | 1996-10-16 | Grupo Grifols, S.A. | Process and apparatus for the determination of the coagulation time of blood and plasma |
JPH0559415A (en) * | 1991-09-02 | 1993-03-09 | Kobe Steel Ltd | Apparatus for estimating furnace heat variation in blast furnace |
WO1993007491A1 (en) | 1991-10-04 | 1993-04-15 | Board Of Regents Of The University Of Nebraska | A soluble thrombomodulin-based one-stage assay for vitamin k-dependent coagulation-inhibiting proteins |
US5716795A (en) | 1991-10-04 | 1998-02-10 | Matschiner; John T. | Thrombomodulin-based coagulometric assay of the protein C system |
EP0642667B1 (en) | 1991-11-04 | 2001-01-10 | Adeza Biomedical Corporation | Screening method for identifying women at increased risk for preterm delivery |
JPH05180835A (en) | 1991-12-27 | 1993-07-23 | S R L:Kk | Measurement of loops anti-coagulant |
US5318958A (en) | 1992-05-29 | 1994-06-07 | Queen's University At Kingston | Amyloid precursor protein |
JP2934557B2 (en) | 1992-07-10 | 1999-08-16 | 国際試薬株式会社 | Blood coagulation time measuring method and apparatus |
JPH0636061A (en) | 1992-07-21 | 1994-02-10 | Fujitsu Ltd | Learning system of hierarchic neural network |
DE4224621C2 (en) * | 1992-07-25 | 1994-05-05 | Boehringer Mannheim Gmbh | Method for analyzing a component of a medical sample using an automatic analysis device |
US5388164A (en) | 1992-08-19 | 1995-02-07 | Olympus Optical Co., Ltd. | Method for judging particle agglutination patterns using neural networks |
JP3224607B2 (en) | 1992-09-11 | 2001-11-05 | 株式会社アズウェル | Method for measuring blood coagulation factor XIII activity and reagent kit for the measurement |
US5369484A (en) | 1992-11-09 | 1994-11-29 | Akzo N.V. | Multiple discrete analyzer test apparatus and method |
US5358852A (en) | 1992-12-21 | 1994-10-25 | Eastman Kodak Company | Use of calcium in immunoassay for measurement of C-reactive protein |
RU2070327C1 (en) | 1992-12-25 | 1996-12-10 | Безруков Александр Васильевич | Device for measurement of coagulation time |
US5344754A (en) | 1993-01-13 | 1994-09-06 | Avocet Medical, Inc. | Assay timed by electrical resistance change and test strip |
JP2938302B2 (en) | 1993-02-25 | 1999-08-23 | 国際試薬株式会社 | Blood coagulation time measuring method and apparatus |
JPH06249857A (en) | 1993-02-26 | 1994-09-09 | Hitachi Ltd | Automatic analyzing device |
RU2061953C1 (en) | 1993-03-10 | 1996-06-10 | Тюменский государственный медицинский институт МЗ РФ | Method for qualitatively determining general coagulation activity of blood platelets |
US5670329A (en) | 1993-05-28 | 1997-09-23 | Cardiovascular Diagnostics, Inc. | Method and analytical system for performing fibrinogen assays accurately, rapidly and simply using a rotating magnetic field |
WO1995005590A1 (en) | 1993-08-16 | 1995-02-23 | Akzo Nobel N.V. | Method and instrument for automatically performing analysis relating to thrombosis and hemostasis |
US5526111A (en) | 1993-08-31 | 1996-06-11 | Boehringer Mannheim Corporation | Method and apparatus for calculating a coagulation characteristic of a sample of blood a blood fraction or a control |
US5472852A (en) | 1993-09-15 | 1995-12-05 | Oklahoma Medical Research Foundation | Assay for detection of selective Protein C inhibition by patients |
US5473732A (en) | 1993-11-02 | 1995-12-05 | Chang; Hou-Mei H. | Relational artificial intelligence system |
US5553616A (en) | 1993-11-30 | 1996-09-10 | Florida Institute Of Technology | Determination of concentrations of biological substances using raman spectroscopy and artificial neural network discriminator |
WO1995030154A1 (en) | 1994-04-28 | 1995-11-09 | Dade International Inc. | Calibrator for prothrombin time (pt) assays |
WO1996006624A1 (en) | 1994-08-26 | 1996-03-07 | Immtech International, Inc. | A mutant protein and methods and materials for making and using it |
US5504011A (en) | 1994-10-21 | 1996-04-02 | International Technidyne Corporation | Portable test apparatus and associated method of performing a blood coagulation test |
SE9403833D0 (en) | 1994-11-08 | 1994-11-08 | Global Hemostasis Inst Mgr Ab | Analysis procedure and kit |
US5567596A (en) | 1994-12-29 | 1996-10-22 | Research Foundation Of State University Of New York | Rapid assay of activators and inhibitors of clotting |
US6207399B1 (en) | 1995-01-10 | 2001-03-27 | Hendrik Coenraad Hemker | Methods of determining endogenous thrombin potential (ETP) and thrombin substrates for use in said methods |
US5708591A (en) | 1995-02-14 | 1998-01-13 | Akzo Nobel N.V. | Method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions |
US6321164B1 (en) | 1995-06-07 | 2001-11-20 | Akzo Nobel N.V. | Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade |
US5780255A (en) | 1995-06-09 | 1998-07-14 | Instrumentation Laboratory, S.P.A. | Protein C pathway screening test |
AU711163B2 (en) | 1995-07-21 | 1999-10-07 | Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin, The | Method for the quantitative measurement of human acute phase serum amyloid a protein; recombinant protein; specific antibody |
US5766869A (en) | 1995-11-30 | 1998-06-16 | Ahs Hospital Corp. | Factor V ratio blood test for susceptibility to thromboembolism |
ES2231860T3 (en) | 1996-03-22 | 2005-05-16 | Dade Behring Inc. | CONSERVATION AND TESTING DEVICE DEVICES USED IN COMBINATION. |
JPH1026621A (en) | 1996-07-12 | 1998-01-27 | Dai Ichi Pure Chem Co Ltd | Immunoassay method |
US5684007A (en) | 1996-09-05 | 1997-11-04 | Otsuka Pharmaceutical Co., Ltd. | Methods for inhibiting cardiac fibroblast growth and cardiac fibrosis |
JP3876022B2 (en) | 1996-09-26 | 2007-01-31 | 生化学工業株式会社 | Method for quantifying substances that affect blood clotting time |
US5981285A (en) | 1996-10-21 | 1999-11-09 | Carroll; Wallace E. | Method and apparatus for determining anticoagulant therapy factors |
EP0841566A1 (en) | 1996-11-11 | 1998-05-13 | Pentapharm A.G. | Positive control plasma for lupus anticoagulant |
ATE530180T1 (en) | 1997-04-02 | 2011-11-15 | Brigham & Womens Hospital | METHOD FOR DETERMINING THE INDIVIDUAL RISK PROFILES OF ATHEROSCLEROTIC DISEASES |
US6010911A (en) | 1997-04-30 | 2000-01-04 | Medtronic, Inc. | Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique |
ATE203567T1 (en) | 1998-03-19 | 2001-08-15 | Instrumentation Lab Spa | IMPROVED IN VITRO PROCEDURES, TEST KITS AND REAGENTS FOR SCREENING BLOOD CLOTTING DEFECTS |
-
1999
- 1999-06-30 US US09/345,080 patent/US6502040B2/en not_active Expired - Fee Related
-
2000
- 2000-06-30 WO PCT/US2000/018310 patent/WO2001001152A1/en active IP Right Grant
- 2000-06-30 CA CA002377528A patent/CA2377528C/en not_active Expired - Lifetime
- 2000-06-30 ES ES00947001T patent/ES2270850T3/en not_active Expired - Lifetime
- 2000-06-30 KR KR1020017016754A patent/KR20020042539A/en not_active Application Discontinuation
- 2000-06-30 JP JP2001507105A patent/JP2003529046A/en active Pending
- 2000-06-30 EP EP00947001A patent/EP1188060B1/en not_active Expired - Lifetime
- 2000-06-30 AT AT00947001T patent/ATE328327T1/en not_active IP Right Cessation
- 2000-06-30 AU AU60676/00A patent/AU768436B2/en not_active Expired
- 2000-06-30 DE DE60028374T patent/DE60028374T2/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5856114A (en) * | 1994-03-21 | 1999-01-05 | The University Of Vermont | Immunologic detection of factor VA fragments in hemorrhagic and thrombotic clinical settings |
US5834223A (en) * | 1994-11-14 | 1998-11-10 | The Scripps Research Institute | Method for diagnosis of thrombotic disorders |
US5715821A (en) * | 1994-12-09 | 1998-02-10 | Biofield Corp. | Neural network method and apparatus for disease, injury and bodily condition screening or sensing |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008040827A1 (en) | 2006-10-02 | 2008-04-10 | Lafuente Flo, Rosa | Improved cover for motorcycle helmets |
Also Published As
Publication number | Publication date |
---|---|
AU768436B2 (en) | 2003-12-11 |
US6502040B2 (en) | 2002-12-31 |
WO2001001152A9 (en) | 2002-05-02 |
CA2377528C (en) | 2008-02-05 |
US20020010553A1 (en) | 2002-01-24 |
AU6067600A (en) | 2001-01-31 |
JP2003529046A (en) | 2003-09-30 |
CA2377528A1 (en) | 2001-01-04 |
DE60028374D1 (en) | 2006-07-06 |
ES2270850T3 (en) | 2007-04-16 |
DE60028374T2 (en) | 2007-06-06 |
ATE328327T1 (en) | 2006-06-15 |
EP1188060A1 (en) | 2002-03-20 |
EP1188060A4 (en) | 2005-04-13 |
EP1188060B1 (en) | 2006-05-31 |
KR20020042539A (en) | 2002-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Christensen et al. | Precision and accuracy of point‐of‐care testing coagulometers used for self‐testing and self‐management of oral anticoagulation therapy | |
CA2316361C (en) | A method for predicting an abnormal level of clotting proteins | |
EP0834145B1 (en) | A method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions | |
Harrison et al. | Screening tests of platelet function: update on their appropriate uses for diagnostic testing | |
AU774889B2 (en) | A method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample | |
US20130344519A1 (en) | Methods and systems for assessment of turbidity kinetics (waveform analysis) in coagulation testing | |
Van den Besselar | A comparison of INRs determined with a whole blood prothrombin time device and two international reference preparations for thromboplastin | |
US6898532B1 (en) | Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample | |
CA2377528C (en) | Method and apparatus for presenting thrombosis and hemostasis assay data | |
Joist | Hypercoagulability: introduction and perspective | |
Pîrlog et al. | The applicability of thromboelastography in acute ischemic stroke: A literature review | |
US20100235103A1 (en) | Method and apparatus for evaluating prothrombotic conditions | |
de Laat-Kremers et al. | Deciphered coagulation profile to diagnose the antiphospholipid syndrome using artificial intelligence | |
AU2004201011B2 (en) | Method and apparatus for presenting thrombosis and hemostasis assay data | |
EP1907866B1 (en) | Method and apparatus for determining anticoagulant therapy factors | |
US20090191637A1 (en) | Method and apparatus for determining anticoagulant therapy factors | |
Perifanis et al. | Update on laboratory testing and hemostasis assessment in patients receiving direct oral anticoagulants (DOACs) | |
Givens et al. | Classification of factor deficiencies from coagulation assays using neural networks | |
Cook et al. | Laboratory Instrumentation, Reagents, Methods, and Patient Sample as Variables in Coagulation | |
EP1522860A1 (en) | A method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample | |
Garcia Scaglioni | A Laplace domain approach to the modeling of von Willebrand disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA JP KR US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2377528 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2001 507105 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 60676/00 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020017016754 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000947001 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000947001 Country of ref document: EP |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1/7-7/7, DRAWINGS, REPLACED BY NEW PAGES 1/7-7/7; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
WWG | Wipo information: grant in national office |
Ref document number: 2000947001 Country of ref document: EP |